CatalystPit

SPRYARS Pharmaceuticals, Inc.

NASDAQ · PHARMACEUTICAL PREPARATIONS
Last close $4.31 · 2026-09-30
ABOUT
ExchangeNASDAQ
SectorHealthcare
IndustryPHARMACEUTICAL PREPARATIONS
Market cap$428.62M
CountryUSA
RECENT INSIDER TRADES
  • 2026-06-12 · Karas Eric (Chief Commercial Officer) · SELL
  • 2026-06-12 · Karas Eric (Chief Commercial Officer) · OTHER
  • 2026-06-12 · Fitzpatrick Alexander A (Chief Legal Officer) · SELL
  • 2025-11-14 · Dorsey Brian (Chief Operating Officer) · SELL
  • 2025-11-14 · Chakma Justin (Chief Business Officer) · SELL
INSTITUTIONAL OWNERSHIP
Institutional holders224
Shares held99,020,608
Value$794.47M
Percent of shares outstanding99.57%
As of quarter end2026-06-30
RECENT NEWS
  • SPRY: ARS Pharmaceuticals, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - SPRY
  • SPRY: ARS PHARMACEUTICALS DEADLINE: ROSEN, LEADING INVESTOR COUNSEL, Encourages ARS Pharmaceuticals, Inc
  • SPRY EQUITY ACTION REMINDER: Faruqi & Faruqi, LLP Reminds ARS Pharmaceuticals Investors of Securities Class Action Lawsuit Deadline on October 5, 2026
  • SPRY: ARS PHARMACEUTICALS DEADLINE: ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages ARS Pharmaceuticals, Inc
  • SPRY: ARS Pharmaceuticals Deadline: SPRY Investors Have Opportunity to Lead ARS Pharmaceuticals, Inc. Securities Fraud Lawsuit
CatalystPit
FeaturesComing soonPricingComing soonPrivacyTermsDisclaimerAffiliate TermsContact
2026 CATALYSTPIT · NOT FINANCIAL ADVICE · DELAYED FILINGS
ARS Pharmaceuticals, Inc. (SPRY) · Stock Price, Insider Trades, Institutional Holdings · CatalystPit